Simulations for designing and interpreting intervention trials in infectious diseases

<h4>Background</h4> <p>Interventions in infectious diseases can have both direct effects on individuals who receive the intervention as well as indirect effects in the population. In addition, intervention combinations can have complex interactions at the population level, which a...

Full description

Bibliographic Details
Main Authors: Halloran, ME, Auranen, K, Baird, S, Brookmeyer, R, Cooper, BS, DeGruttola, V, Hughes, JP, Lessler, J, Lofgren, ET, Longini, IM, Onnela, J-P, Özler, B, Vespignani, A, Vynnycky, E, Lipsitch, M
Format: Journal article
Language:English
Published: 2018
_version_ 1826268702886068224
author Halloran, ME
Auranen, K
Baird, S
Brookmeyer, R
Cooper, BS
DeGruttola, V
Hughes, JP
Lessler, J
Lofgren, ET
Longini, IM
Onnela, J-P
Özler, B
Vespignani, A
Vynnycky, E
Lipsitch, M
author_facet Halloran, ME
Auranen, K
Baird, S
Brookmeyer, R
Cooper, BS
DeGruttola, V
Hughes, JP
Lessler, J
Lofgren, ET
Longini, IM
Onnela, J-P
Özler, B
Vespignani, A
Vynnycky, E
Lipsitch, M
author_sort Halloran, ME
collection OXFORD
description <h4>Background</h4> <p>Interventions in infectious diseases can have both direct effects on individuals who receive the intervention as well as indirect effects in the population. In addition, intervention combinations can have complex interactions at the population level, which are often difficult to adequately assess with standard study designs and analytical methods.</p> <h4>Discussion</h4> <p>Herein, we urge the adoption of a new paradigm for the design and interpretation of intervention trials in infectious diseases, particularly with regard to emerging infectious diseases, one that more accurately reflects the dynamics of the transmission process. In an increasingly complex world, simulations can explicitly represent transmission dynamics, which are critical for proper trial design and interpretation. Certain ethical aspects of a trial can also be quantified using simulations. Further, after a trial has been conducted, simulations can be used to explore the possible explanations for the observed effects.</p> <h4>Conclusion</h4> <p>Much is to be gained through a multidisciplinary approach that builds collaborations among experts in infectious disease dynamics, epidemiology, statistical science, economics, simulation methods, and the conduct of clinical trials.</p>
first_indexed 2024-03-06T21:13:41Z
format Journal article
id oxford-uuid:3f0b1d1e-8495-4489-872c-c8cfc76ce5b4
institution University of Oxford
language English
last_indexed 2024-03-06T21:13:41Z
publishDate 2018
record_format dspace
spelling oxford-uuid:3f0b1d1e-8495-4489-872c-c8cfc76ce5b42022-03-26T14:29:27ZSimulations for designing and interpreting intervention trials in infectious diseasesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3f0b1d1e-8495-4489-872c-c8cfc76ce5b4EnglishSymplectic Elements at Oxford2018Halloran, MEAuranen, KBaird, SBrookmeyer, RCooper, BSDeGruttola, VHughes, JPLessler, JLofgren, ETLongini, IMOnnela, J-PÖzler, BVespignani, AVynnycky, ELipsitch, M <h4>Background</h4> <p>Interventions in infectious diseases can have both direct effects on individuals who receive the intervention as well as indirect effects in the population. In addition, intervention combinations can have complex interactions at the population level, which are often difficult to adequately assess with standard study designs and analytical methods.</p> <h4>Discussion</h4> <p>Herein, we urge the adoption of a new paradigm for the design and interpretation of intervention trials in infectious diseases, particularly with regard to emerging infectious diseases, one that more accurately reflects the dynamics of the transmission process. In an increasingly complex world, simulations can explicitly represent transmission dynamics, which are critical for proper trial design and interpretation. Certain ethical aspects of a trial can also be quantified using simulations. Further, after a trial has been conducted, simulations can be used to explore the possible explanations for the observed effects.</p> <h4>Conclusion</h4> <p>Much is to be gained through a multidisciplinary approach that builds collaborations among experts in infectious disease dynamics, epidemiology, statistical science, economics, simulation methods, and the conduct of clinical trials.</p>
spellingShingle Halloran, ME
Auranen, K
Baird, S
Brookmeyer, R
Cooper, BS
DeGruttola, V
Hughes, JP
Lessler, J
Lofgren, ET
Longini, IM
Onnela, J-P
Özler, B
Vespignani, A
Vynnycky, E
Lipsitch, M
Simulations for designing and interpreting intervention trials in infectious diseases
title Simulations for designing and interpreting intervention trials in infectious diseases
title_full Simulations for designing and interpreting intervention trials in infectious diseases
title_fullStr Simulations for designing and interpreting intervention trials in infectious diseases
title_full_unstemmed Simulations for designing and interpreting intervention trials in infectious diseases
title_short Simulations for designing and interpreting intervention trials in infectious diseases
title_sort simulations for designing and interpreting intervention trials in infectious diseases
work_keys_str_mv AT halloranme simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT auranenk simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT bairds simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT brookmeyerr simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT cooperbs simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT degruttolav simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT hughesjp simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT lesslerj simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT lofgrenet simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT longiniim simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT onnelajp simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT ozlerb simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT vespignania simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT vynnyckye simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases
AT lipsitchm simulationsfordesigningandinterpretinginterventiontrialsininfectiousdiseases